GUVVALI, DHARMENDER, and DIBYALOCHAN MOHANTY. “A QUALITY BY DESIGN DRIVEN DEVELOPMENT AND CHARACTERIZATION OF PALBOCICLIB-LOADED MESOPOROUS SILICA NANOPARTICLES IN HEPATOCELLULAR CARCINOMA THERAPY: ASSESSMENT OF CYTOTOXIC AND APOPTOTIC EFFECTS ON HEPG2 CELL LINE”. International Journal of Applied Pharmaceutics, vol. 18, no. 3, Apr. 2026, doi:10.22159/ijap.2026v18i3.57785.